Your browser doesn't support javascript.
loading
Analysis of dengue specific memory B cells, neutralizing antibodies and binding antibodies in healthy adults from India.
Gunisetty, Sivaram; Nayak, Kaustuv; Chandra Rai, Ramesh; Chawla, Yadya; Reddy, Elluri Seetharami; Aggarwal, Charu; Maheshwari, Deepti; Panda, Harekrushna; Ansari, Nasim Akhtar; Singh, Prabhat; Kaur, Manpreet; Dixit, Kritika; Sharma, Pragati; Bhatnagar, Priya; Priyamvada, Lalita; Bhaumik, Siddhartha Kumar; Ahamed, Syed Fazil; Vivek, Rosario; Ray, Pratima; Shet, Anita; Coshic, Poonam; Lodha, Rakesh; Kabra, Sushil Kumar; Afroze, Dil; Yousuf, Adfar; Ahmed, Rafi; Murali-Krishna, Kaja; Chandele, Anmol.
Afiliação
  • Gunisetty S; ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India; Department of Pediatrics, Division of Infectious Disease, Emory University School of Medicine, Atlanta, GA, USA; Emory Vaccine Center, Emory University School of
  • Nayak K; ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
  • Chandra Rai R; ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
  • Chawla Y; ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
  • Reddy ES; ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
  • Aggarwal C; ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
  • Maheshwari D; ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
  • Panda H; ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
  • Ansari NA; ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
  • Singh P; ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
  • Kaur M; ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
  • Dixit K; ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
  • Sharma P; ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
  • Bhatnagar P; ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India.
  • Priyamvada L; Department of Pediatrics, Division of Infectious Disease, Emory University School of Medicine, Atlanta, GA, USA.
  • Bhaumik SK; Department of Pediatrics, Division of Infectious Disease, Emory University School of Medicine, Atlanta, GA, USA.
  • Ahamed SF; Division of Infectious Diseases, St. John's Research Institute, St. John's National Academy of Health Sciences, Koramangala, Bangalore, 560034, India; The University of Trans-Disciplinary Health Sciences & Technology, Bangalore, 560064, Karnataka, India.
  • Vivek R; Division of Infectious Diseases, St. John's Research Institute, St. John's National Academy of Health Sciences, Koramangala, Bangalore, 560034, India.
  • Ray P; Department of Biotechnology, School of Clinical and Life Sciences, Jamia Hamdard, Mehrauli-Bardarpur Road, New Delhi, 110062, India.
  • Shet A; Division of Infectious Diseases, St. John's Research Institute, St. John's National Academy of Health Sciences, Koramangala, Bangalore, 560034, India; International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, 415 N Washington St, Baltimore, 21231, USA.
  • Coshic P; Department of Transfusion Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
  • Lodha R; Division of Pediatric Pulmonology and Intensive Care, Department of Pediatrics, AIIMS, New Delhi, India.
  • Kabra SK; Division of Pediatric Pulmonology and Intensive Care, Department of Pediatrics, AIIMS, New Delhi, India.
  • Afroze D; Immunology & Molecular Medicine, Sher-i-Kashmir Institute of Medical Sciences-Srinagar, Jammu and Kashmir, 190011, India.
  • Yousuf A; Immunology & Molecular Medicine, Sher-i-Kashmir Institute of Medical Sciences-Srinagar, Jammu and Kashmir, 190011, India.
  • Ahmed R; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, 30322, USA; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, 30322, USA.
  • Murali-Krishna K; ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India; Department of Pediatrics, Division of Infectious Disease, Emory University School of Medicine, Atlanta, GA, USA; Emory Vaccine Center, Emory University School of
  • Chandele A; ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India. Electronic address: chandeleanmol@gmail.com.
Int J Infect Dis ; 84S: S57-S63, 2019 Jul.
Article em En | MEDLINE | ID: mdl-30658170
ABSTRACT

BACKGROUND:

The Indian population is facing highest dengue burden worldwide supporting an urgent need for vaccines. For vaccine introduction, evaluation and interpretation it is important to gain a critical understanding of immune memory induced by natural exposure. However, immune memory to dengue remains poorly characterized in this region.

METHODS:

We enumerated levels of dengue specific memory B cells (MBC), neutralizing (NT) and binding antibodies in healthy adults (n=70) from New Delhi.

RESULTS:

NT-antibodies, binding antibodies and MBC were detectable in 86%, 86.56% and 81.63% of the subjects respectively. Among the neutralizing positive subjects, 58%, 27%, 5% and 10% neutralized all four, any three, any two and any one dengue serotypes respectively. The presence of the neutralizing antibodies was associated with the presence of the MBC and binding antibodies. However, a massive interindividual variation was observed in the levels of the neutralizing antibodies (range, <150-130,264), binding antibodies (range, 13,000-1134,000,) as well as the MBC (range=0.006%-5.05%).

CONCLUSION:

These results indicate that a vast majority of the adults are immune to multiple dengue serotypes and show massive interindividual variation in neutralizing/binding antibodies and MBCs - emphasizing the importance of monitoring multiple parameters of immune memory in order to properly plan, evaluate and interpret dengue vaccines.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos B / Dengue / Vírus da Dengue / Anticorpos Neutralizantes / Anticorpos Antivirais Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos B / Dengue / Vírus da Dengue / Anticorpos Neutralizantes / Anticorpos Antivirais Idioma: En Ano de publicação: 2019 Tipo de documento: Article